# Do GLP-1 Drugs Help Diabetic Neuropathy? | Buy This GLP

See what studies found about GLP-1 drugs, diabetic nerve damage, foot ulcers and Charcot foot, plus when foot symptoms need urgent evaluation.

Publisher: Buy This GLP Editorial Team
Canonical: https://buythisglp.com/research/do-glp1-drugs-help-diabetic-neuropathy
Updated: 2026-11-15
Published: 2026-09-17

[← Research](https://buythisglp.com/research)

Evidence

# Do GLP-1 Drugs Help Diabetic Neuropathy?

A records study found fewer foot ulcers and more Charcot diagnoses. Direct research on whether GLP-1 drugs improve nerve function remains limited.

Editorial profile: [Carla Medina](https://buythisglp.com/authors/carla-medina)[Buy This GLP Editorial Team](https://buythisglp.com/about)September 20265 min readUpdated November 2026

One-year rates — GLP-1 above, DPP-4 below · foot ulcer · 2.2% / 2.7% · amputation · 0.5% / 0.5% · osteomyelitis · 0.4% / 0.4% · Charcot foot · 0.3% / 0.2% · 19,770 matched patients per group, all with diabetic neuropathy.

**Research, not medical advice.** Buy This GLP is independent and educational. Nothing here is a substitute for individualized care from a licensed clinician, and reading it creates no doctor–patient relationship. Talk to your own provider before starting, stopping, or changing any medication, peptide, or therapy. See our [methodology](https://buythisglp.com/methodology) and [terms](https://buythisglp.com/terms).

## Key takeaways

-   In a matched records study, people with diabetic neuropathy who started a GLP-1 drug had fewer recorded foot ulcers and more Charcot foot diagnoses than those starting a DPP-4 inhibitor.
-   A small randomized trial found no clear improvement in nerve function with exenatide versus insulin glargine.
-   An open sore or an unexplained warm, swollen or red foot needs urgent evaluation if you have diabetic neuropathy.

Studies of [walking ability in peripheral artery disease](https://buythisglp.com/research/do-glp1-drugs-help-peripheral-artery-disease) answer a different question from whether a GLP-1 drug can repair nerves affected by diabetes. The largest neuropathy study discussed here tracked foot complications in health records. Smaller studies evaluated nerve function and pain directly.

## What the foot complication study found

Researchers matched 19,770 adults with type 2 diabetes and neuropathy starting a GLP-1 receptor agonist to 19,770 starting a DPP-4 inhibitor. At one year, a foot ulcer had been recorded for 2.2% versus 2.7%, a difference of about five per 1,000 people (hazard ratio 0.813, 95% CI 0.716 to 0.922) [\[1\]](https://buythisglp.com/research/do-glp1-drugs-help-diabetic-neuropathy#ref-1).

Charcot neuroarthropathy, which damages bones and joints in a foot with reduced sensation, was recorded in 0.3% versus 0.2%, a difference of roughly one per 1,000 based on the rounded rates. The hazard ratio was 1.993 (95% CI 1.297 to 3.064). Amputation and bone infection rates were similar in both groups. This observational study did not measure nerve function or show whether the drugs caused the differences.

## Do GLP-1 drugs improve nerve function?

In a small, open-label randomized trial of 46 adults with type 2 diabetes and mild to moderate neuropathy, 18 months of exenatide showed no statistically significant advantage over insulin glargine on measured neuropathy outcomes, including nerve conduction and nerve fiber density[\[2\]](https://buythisglp.com/research/do-glp1-drugs-help-diabetic-neuropathy#ref-2).

A 2026 cross-sectional study evaluated 500 adults with type 2 diabetes. It found painful neuropathy in 10.1% of people already taking a GLP-1 drug versus 35.1% of those on standard treatment and 28.3% of those taking an SGLT2 inhibitor [\[3\]](https://buythisglp.com/research/do-glp1-drugs-help-diabetic-neuropathy#ref-3). Because the researchers assessed the groups at one point in time, they could not tell whether the medication came before the difference in symptoms or whether treatment improved anyone’s nerve function.

When to get foot symptoms checked

The American Diabetes Association recommends urgent assessment of an open foot sore or unexplained redness, swelling or warmth. In a person with neuropathy, a warm, swollen, red foot can require evaluation for Charcot even when there is no open wound [\[4\]](https://buythisglp.com/research/do-glp1-drugs-help-diabetic-neuropathy#ref-4).

## Frequently asked

Do GLP-1 drugs reverse diabetic neuropathy?

That has not been established. A small randomized exenatide trial found no clear improvement in nerve measures over insulin glargine. The larger records study measured foot complications instead of nerve function.

What did the study find about Charcot foot?

Charcot neuroarthropathy was recorded in 0.3% of patients starting a GLP-1 drug and 0.2% of matched patients starting a DPP-4 inhibitor. The study cannot establish what caused the difference.

## Sources

1.  \[1\] Tawfik F, et al. (2026). GLP-1 receptor agonists vs DPP-4 inhibitors and neuropathic complications in type 2 diabetes Journal of Neurology. [PMID 42704495](https://pubmed.ncbi.nlm.nih.gov/42704495/)
2.  \[2\] Jaiswal M, et al. (2015). Effects of Exenatide on Measures of Diabetic Neuropathy in Subjects with Type 2 Diabetes: Results from an 18-Month Proof-of-Concept Open-Label Randomized Study Journal of Diabetes and Its Complications. [Source](https://pmc.ncbi.nlm.nih.gov/articles/PMC4656068/)
3.  \[3\] Falco P, et al. (2026). Glucagon-like peptide-1 receptor agonist treatment is associated with lower frequency of diabetic peripheral neuropathy and neuropathic pain in type 2 diabetes Pain. [PMID 42663556](https://pubmed.ncbi.nlm.nih.gov/42663556/)
4.  \[4\] American Diabetes Association Professional Practice Committee (2026). Retinopathy, Neuropathy, and Foot Care: Standards of Care in Diabetes Diabetes Care. [Source](https://doi.org/10.2337/dc26-S012)

## Where to get it

### Price the injectable sellers

The desk lists every seller that publishes an injectable figure, with the advertised price struck against the one a buyer is billed.

[Open the price desk →](https://buythisglp.com/)

## More in Evidence

-   [
    
    50,678 adults with a BMI of 30 or more · Prescribed · 8.0% · Filled · 4.4% · Outlined bar runs to 10%. Medicaid had lower odds of both.
    
    ### Does Medicaid Cover Weight Loss Drugs? It Depends on Your State
    
    ](https://buythisglp.com/research/does-medicaid-cover-weight-loss-drugs)
-   [
    
    What the claim rests on · Sleep study · AHI 15 or more · Obesity · BMI 30 or more · Prescription · for sleep apnea · Part D claim · plan review · Trial thresholds shown. Your plan sets its approval requirements.
    
    ### Does Medicare Cover Zepbound for Sleep Apnea? The Diagnosis Is the Key
    
    ](https://buythisglp.com/research/does-medicare-cover-zepbound-for-sleep-apnea)
-   [
    
    Illustrative decline with a one-week half-life · Ozempic window: up to 5 days late · 100% · day 0 · 82% · day 2 · 67% · day 4 · 61% · day 5 · 50% · day 7 · A calculation from the label half-life, not a blood test.
    
    ### What Happens If You Miss a Dose of Ozempic? A Week-Long Half-Life Buys Time
    
    ](https://buythisglp.com/research/what-happens-if-you-miss-a-dose-of-ozempic)
